CHARLOTTESVILLE, Va., Jan.

Koronis Pharmaceuticals, Inc., a biotechnology company focused on the development of antiviral therapeutics, today announced that Courtney Fletcher, Pharm. D., will join the Company's Scientific Advisory Board and Jeff Parkins has been promoted to Vice President, Clinical Development. Dr.

To: NATIONAL EDITORS Contact: Holly Barkhymer, +1-212-509-0995 ext. 242, hbarkhymer@michaeljfox.org, or Todd Sherer, PhD, +1-212-509-0995 ext. 243, tsherer@michaeljfox.org, both of the Michael J.

Research and Markets (http://www.researchandmarkets.com/reports/c75212) has announced the addition of "G Protein-coupled Receptors: Molecular Pharmacology" to their offering.

CHARLESTON, S.C., March 12 /PRNewswire/ -- Science, medicine and business interests will converge on Kiawah Island March 23-24 for the 2007 Hollings Cancer Center Spring Symposium to discuss the science, clinical testing and business aspects underlying the development of novel cancer therapeutics.